Moderna reported falling fourth-quarter sales as Covid-19 vaccine demand continued to drop, but continues to target 10% ...

When people get the shots, the body’s immune system can accidentally confuse a normal protein from adenovirus - which is used ...

New data provide additional reassuring evidence that COVID vaccination before or during pregnancy does not increase autism risk in young children.

Moderna (NASDAQ: MRNA) reported fourth-quarter results Friday morning that beat Wall Street’s muted expectations, delivering ...

Moderna beat fourth-quarter sales expectations and forecast growth for 2026, but an FDA refusal on its flu vaccine raises new ...

The FDA declined to review Moderna's mRNA influenza vaccine due to inadequate clinical trial comparators for older adults.

Feb 13 (Reuters) - Moderna reported fourth-quarter revenue above Wall Street estimates on Friday, helped by sales of its COVID-19 vaccine. The company has been struggling financially as demand for ...

Health and Human Services (HHS) Secretary Robert F. Kennedy Jr.’s first year in office has upended decades of public health ...

HealthDay News — More than four in 10 people older than 50 years (42 percent) have not gotten either a flu or COVID-19 vaccine, according to the results of a survey conducted by the University of ...

Q4 2025 earnings call highlights: revenue, cost cuts, cash outlook, FDA flu setback, and 2026 growth guidance—read key insights now.

Flu activity remains elevated across Tennessee, with parts of East Tennessee reporting some of the highest levels of ...